355 related articles for article (PubMed ID: 33670230)
1. Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma.
Thakur G; Kumar R; Kim SB; Lee SY; Lee SL; Rho GJ
Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33670230
[TBL] [Abstract][Full Text] [Related]
2. Potentials of "stem cell-therapy" in pancreatic cancer: An update.
Chopra N; Choudhury S; Bhargava S; Wajid S; Ganguly NK
Pancreatology; 2019 Dec; 19(8):1034-1042. PubMed ID: 31668563
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy.
Sarantis P; Koustas E; Papadimitropoulou A; Papavassiliou AG; Karamouzis MV
World J Gastrointest Oncol; 2020 Feb; 12(2):173-181. PubMed ID: 32104548
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic cancer stem cells: Perspectives on potential therapeutic approaches of pancreatic ductal adenocarcinoma.
Di Carlo C; Brandi J; Cecconi D
World J Stem Cells; 2018 Nov; 10(11):172-182. PubMed ID: 30631392
[TBL] [Abstract][Full Text] [Related]
5. [Regulatory effect of miR-30b on migration and invasion of pancreatic cancer stem cells].
Guo QS; Wang P; Huang Y; Guo YB; Zhu MY; Xiong YC
Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(38):3019-3023. PubMed ID: 31607036
[No Abstract] [Full Text] [Related]
6. A Novel Approach for Image-Guided
Schug C; Gupta A; Urnauer S; Steiger K; Cheung PF; Neander C; Savvatakis K; Schmohl KA; Trajkovic-Arsic M; Schwenk N; Schwaiger M; Nelson PJ; Siveke JT; Spitzweg C
Mol Cancer Res; 2019 Jan; 17(1):310-320. PubMed ID: 30224540
[TBL] [Abstract][Full Text] [Related]
7. The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications.
Liu X; Xu J; Zhang B; Liu J; Liang C; Meng Q; Hua J; Yu X; Shi S
Mol Cancer; 2019 Dec; 18(1):184. PubMed ID: 31831007
[TBL] [Abstract][Full Text] [Related]
8. The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling.
Maity G; Haque I; Ghosh A; Dhar G; Gupta V; Sarkar S; Azeem I; McGregor D; Choudhary A; Campbell DR; Kambhampati S; Banerjee SK; Banerjee S
J Biol Chem; 2018 Mar; 293(12):4334-4349. PubMed ID: 29414775
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic Cancer Stem Cells and Therapeutic Approaches.
Ercan G; Karlitepe A; Ozpolat B
Anticancer Res; 2017 Jun; 37(6):2761-2775. PubMed ID: 28551612
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC).
Chandana S; Babiker HM; Mahadevan D
Expert Opin Investig Drugs; 2019 Feb; 28(2):161-177. PubMed ID: 30539678
[TBL] [Abstract][Full Text] [Related]
11. Targeting the tumor microenvironment for pancreatic ductal adenocarcinoma therapy.
Zhang YF; Jiang SH; Hu LP; Huang PQ; Wang X; Li J; Zhang XL; Nie HZ; Zhang ZG
Chin Clin Oncol; 2019 Apr; 8(2):18. PubMed ID: 31070038
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic cancer stem cells: new insight into a stubborn disease.
Zhan HX; Xu JW; Wu D; Zhang TP; Hu SY
Cancer Lett; 2015 Feb; 357(2):429-37. PubMed ID: 25499079
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow mesenchymal stem cells-derived exosomes for penetrating and targeted chemotherapy of pancreatic cancer.
Zhou Y; Zhou W; Chen X; Wang Q; Li C; Chen Q; Zhang Y; Lu Y; Ding X; Jiang C
Acta Pharm Sin B; 2020 Aug; 10(8):1563-1575. PubMed ID: 32963950
[TBL] [Abstract][Full Text] [Related]
14. PKM2 Promotes Cell Survival and Invasion Under Metabolic Stress by Enhancing Warburg Effect in Pancreatic Ductal Adenocarcinoma.
Li C; Zhao Z; Zhou Z; Liu R
Dig Dis Sci; 2016 Mar; 61(3):767-73. PubMed ID: 26500118
[TBL] [Abstract][Full Text] [Related]
15. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
16. The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
Lai SW; Bamodu OA; Tsai WC; Chang YM; Lee WH; Yeh CT; Chao TY
Clin Exp Metastasis; 2018 Oct; 35(7):663-677. PubMed ID: 29987671
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects.
Li KY; Yuan JL; Trafton D; Wang JX; Niu N; Yuan CH; Liu XB; Zheng L
Chronic Dis Transl Med; 2020 Mar; 6(1):6-17. PubMed ID: 32226930
[TBL] [Abstract][Full Text] [Related]
18. GM-CSF Mediates Mesenchymal-Epithelial Cross-talk in Pancreatic Cancer.
Waghray M; Yalamanchili M; Dziubinski M; Zeinali M; Erkkinen M; Yang H; Schradle KA; Urs S; Pasca Di Magliano M; Welling TH; Palmbos PL; Abel EV; Sahai V; Nagrath S; Wang L; Simeone DM
Cancer Discov; 2016 Aug; 6(8):886-99. PubMed ID: 27184426
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.
Haqq J; Howells LM; Garcea G; Metcalfe MS; Steward WP; Dennison AR
Eur J Cancer; 2014 Oct; 50(15):2570-82. PubMed ID: 25091797
[TBL] [Abstract][Full Text] [Related]
20. Viro-immune therapy: A new strategy for treatment of pancreatic cancer.
Ibrahim AM; Wang YH
World J Gastroenterol; 2016 Jan; 22(2):748-63. PubMed ID: 26811622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
